BBI Case Studies

Case Studies

We're incredibly proud of our work and our case studies reflect this. 

Digital

Smartphone HIV Test

It is believed that an estimated 35.3 million people are living with HIV globall...

Digital

Rapid Legionella Test

Novarum™ has created a bespoke app and mobile testing solution for the wor...

Digital

Microbial Fuel Contamination Test

Requiring only a droplet of water in fuel to thrive, microbial growth has the po...

Digital

Smartphone calprotectin test

First Calprotectin Home Test Kit In our latest case study we discuss how Novarum...

Digital

Rapid lentivirus smartphone test

Lentiviral vectors have proven to be powerful tools for stable gene transfer to ...

Services

Verax Biomedical

The Challenge Verax was founded upon a single vision – to improve patient ...

No case studies found.

No case studies found.

Services

Verax Biomedical

The Challenge Verax was founded upon a single vision – to improve patient ...

Digital

Smartphone HIV Test

It is believed that an estimated 35.3 million people are living with HIV globall...

Digital

Rapid Legionella Test

Novarum™ has created a bespoke app and mobile testing solution for the wor...

Digital

Microbial Fuel Contamination Test

Requiring only a droplet of water in fuel to thrive, microbial growth has the po...

Digital

Smartphone calprotectin test

First Calprotectin Home Test Kit In our latest case study we discuss how Novarum...

Digital

Rapid lentivirus smartphone test

Lentiviral vectors have proven to be powerful tools for stable gene transfer to ...

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox